In vitro activity of liposomal N4octadecyl-1-β-D-arabinofurano-sylcytosine (NOAC), a new lipophilic derivative of 1-β-D-arabino-furanocylcytosine on biopsized clonogenic human tumor cells and hematopoietic precursor cells R.A. SchwendenerK. FriedlA.-R. Hanauske OriginalPaper Pages: 203 - 210
Tetramethylpiperidine-Substituted Phenazines Inhibit the Proliferation of Intrinsically Multidrug Resistant Carcinoma Cell Lines Esme van NiekerkJohn F. O'SullivanConstance E.J. van Rensburg OriginalPaper Pages: 211 - 217
Mechanisms of Action of the Novel Sulfonamide Anticancer Agent E7070 on Cell Cycle Progression in Human Non-Small Cell Lung Cancer Cells Kazuya FukuokaJitsuo UsudaKazuto Nishio OriginalPaper Pages: 219 - 227
Altretamine for the Treatment of Metastatic Renal Cell Carcinoma – A Hoosier Oncology Group Trial Robin T. ZonJohn McCleanPatrick J. Loehrer Sr. OriginalPaper Pages: 229 - 231
N-Methylformamide in Advanced Squamous Cancer of the Uterine Cervix: An Eastern Cooperative Oncology Group Phase II Trial Lakshmi RajdevZi-Fan YuPeter H. Wiernik OriginalPaper Pages: 233 - 237
Phase II Trial of CI-980 in Patients with Disseminated Malignant Melanoma and no Prior Chemotherapy – A Southwest Oncology Group Study Robert P. WhiteheadJoseph M. UngerVernon K. Sondak OriginalPaper Pages: 239 - 243
Phase II Study of Bryostatin 1 in Patients with Relapsed Multiple Myeloma Mary L. VarterasianPamela A. PembertonAyad M. Al-Katib OriginalPaper Pages: 245 - 247
Phase II Studies of Bryostatin-1 in Patients with Advanced Sarcoma and Advanced Head and Neck Cancer B. BrocksteinB. SamuelsE.E. Vokes OriginalPaper Pages: 249 - 254
A Phase II Trial of Weekly Intravenous Ranpirnase (Onconase®), a Novel Ribonuclease in Patients with Metastatic Kidney Cancer Nicholas J. VogelzangMebea AkliluStanislaw M. Mikulski OriginalPaper Pages: 255 - 260
Phase II Trial of GM-CSF in Advanced Prostate Cancer Robert DreicerWilliam A. SeeEric A. Klein OriginalPaper Pages: 261 - 265